---
$id: https://graph.org.ai/products/commodity/51343507
$type: Product
source: UNSPSC
code: "51343507"
title: "Cidofovir sodium"
class: "51343500"
classTitle: "Antiviral organophosphorus compounds"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cidofovir sodium

**UNSPSC Code**: 51343507
**Class**: [Antiviral organophosphorus compounds](Antiviral organophosphorus compounds.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiviral agent with the molecular formula C8H12N3O6P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M83JB37U61, chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, disodium salt, (s)-, but more generally known as cidofovir sodium, which bears US NIH Compound Identifier 135406. European Medicines Agency schedules cidofovir sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06257MIG. Most nations, for tariff purposes, schedule cidofovir sodium under HS 29335995. SMILES: C1CN(C(=O)NC1N)C[C@@H](CO)OCP(=O)([O-])[O-].[NA+].[NA+].

